Survival-associated meQTLs across different cancer types
We identified 23,432 meQTLs associated with patient overall survival across different cancer types at FDR < 0.05.
Cancer type
|
SNP ID
|
SNP position (hg19)
|
Alleles (A/a)
|
log-rank test p-value
|
Sample size
|
Median survival time AA
|
Median survival time Aa
|
Median survival time aa
|
|
---|---|---|---|---|---|---|---|---|---|
PCPG | rs375299532 | chr15:30900637 | T/G | 0 | 176 | 25.92 | 20.37 | 3.17 | KM Plot |
PCPG | rs375321281 | chr15:30989564 | T/C | 1.11E-16 | 175 | 25.67 | 24.82 | 2.12 | KM Plot |
PCPG | rs3761496 | chr22:50246466 | T/C | 0.000154 | 178 | 25.53 | 20.2 | 15.18 | KM Plot |
PCPG | rs3762179 | chr16:87325912 | C/T | 1.11E-16 | 170 | 23.43 | 30.33 | 2.22 | KM Plot |
PCPG | rs3764258 | chr16:89801014 | C/G | 0.000194 | 174 | 25.87 | 20.28 | 36.37 | KM Plot |
PCPG | rs3764309 | chr16:71787918 | G/C | 1.23E-5 | 172 | 21.95 | 30.93 | 14.5 | KM Plot |
PCPG | rs3764473 | chr18:74536101 | C/T | 6.08E-9 | 176 | 25.6 | 24.83 | 10.17 | KM Plot |
PCPG | rs3769013 | chr2:136556182 | C/T | 0.000207 | 178 | 25.92 | 24.1 | 10.3 | KM Plot |
PCPG | rs3769667 | chr2:24284116 | G/C | 0.00011 | 178 | 25.4 | 26.57 | 17.43 | KM Plot |
PCPG | rs3770495 | chr2:217049741 | G/A | 7.45E-5 | 175 | 25 | 29.43 | 2.93 | KM Plot |
PCPG | rs3770497 | chr2:217047640 | A/G | 6.88E-5 | 176 | 24.7 | 31.68 | 2.93 | KM Plot |
PCPG | rs377160385 | chr16:89847917 | TAA/T | 0.000249 | 173 | 25.87 | 20.2 | 36.37 | KM Plot |
PCPG | rs3772387 | chr3:136647481 | G/A | 0.000296 | 176 | 20.2 | 27.27 | 23.03 | KM Plot |
PCPG | rs3784041 | chr14:74435483 | A/G | 3.19E-6 | 178 | 25.4 | 28.38 | 10.3 | KM Plot |
PCPG | rs3784042 | chr14:74435370 | C/T | 3.57E-6 | 177 | 25.4 | 28.47 | 10.3 | KM Plot |